RESUMEN
Flutamide is a steroid used to treat androgen-dependent disorders and as antiepileptic, but it induces a number of non-desirable side effects. This work was aimed at assaying the effect of flutamide and two novel synthetic steroids on the levels of GABA, glutamine and oxidative stress markers. Male Wistar rats (weight 180 g) received a single diazepam dose (5 mg/kg) 30 min prior to sacrifice (group A). Group B, flutamide; group C, 16ß-methyl-17α-benzoyloxypregnen-4-en-3,20-dione; group D, estrone-3-hemisuccinate; group E, testosterone; group F, progesterone; all administered intraperitoneally at 10 mg/kg, daily for 3 days. Brain and prostate were obtained to assess lipid peroxidation (TBARS), Na(+) , K(+) ATPase activity, reduced glutathione (GSH), γ-amino butiric acid (GABA), glutamine and serotonin (5-HT) concentrations through spectrophotometry, fluorescence and HPLC. GABA levels increased and glutamine decreased in group A (P < 0.05). Total ATPase activity increased in group F and TBARS decreased in group B (P < 0.05). GSH decreased in A, B and C groups. 5-HT increased in group A and the prostate weight was increased in group E. The conclusion is that 16ß-methyl-17α-benzoyloxypregnen-4-en-3,20-dione may be considered novel and promising to treat androgen-dependent diseases and epilepsy, since it showed an antioxidant effect and seemed to impair the GABAergic and serotonergic metabolism.
Asunto(s)
Encéfalo/efectos de los fármacos , Estrona/análogos & derivados , Flutamida/farmacología , Estrés Oxidativo/efectos de los fármacos , Progesterona/análogos & derivados , Próstata/efectos de los fármacos , Ácido gamma-Aminobutírico/metabolismo , Animales , Encéfalo/metabolismo , Diazepam/farmacología , Estrona/farmacología , Glutamina/metabolismo , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Progesterona/farmacología , Próstata/metabolismo , Ratas , Ratas Wistar , Serotonina/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Testosterona/farmacologíaRESUMEN
The purpose of this study was to evaluate the effect of cyproterone acetate (CPA, A) compared with new synthetic steroids 3alpha-acetoxy-5,6-epoxy-16-pregnen-20-one (B) and 17alpha-hydroxy-16beta-methyl-1,4,6-pregnatriene-3,20-dione (C) in rat prostate and brain. Groups of animals were treated either with A, B or C (4 mg kg(-1) day(-1)) by the intraperitoneal route for 5 days. Levels of reduced glutathione (GSH), 5-hydroxy-indole acetic acid (5-HIAA), lipid peroxidation (as thiobarbituric acid reactive substances, TBARS) and the activities of Na(+), K(+)- and total ATPases were assayed in prostate and brain for each group of animals including a control group. No appreciable changes were shown in Na(+), K(+)-ATPase and total ATPases and TBARS on prostate and brain of rats that received A, B and C steroids. However, the levels of GSH and 5-HIAA decreased significantly (P < 0.05) in both tissues for the steroids assayed. It is concluded that CPA and the homologues B and C steroids induce changes in the levels of GSH and serotonin in rat prostate and brain.
Asunto(s)
Biomarcadores/análisis , Encéfalo/metabolismo , Acetato de Ciproterona/farmacología , Estrés Oxidativo/fisiología , Pregnatrienos/farmacología , Pregnenolona/análogos & derivados , Próstata/metabolismo , Serotonina/fisiología , Animales , Encéfalo/efectos de los fármacos , Glutatión/metabolismo , Ácido Hidroxiindolacético/metabolismo , Masculino , Estrés Oxidativo/efectos de los fármacos , Pregnenolona/farmacología , Próstata/efectos de los fármacos , Ratas , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismoRESUMEN
The in vivo and in vitro antiandrogenic activity of four aromatic esters 10a-10d, one aliphatic ester 10e based on the pregna-4,16-diene-6, 20-dione structure and two aromatic 17c, 17d and two aliphatic valeroyloxy esters 17a, 17b based on the more saturated 4-pregnene-6,20-dione skeleton was examined. The biological activity of steroids 9, 10a-10e and 17a-17d, was determined using prostate glands from gonadectomized adult male golden hamsters. In the in vitro studies, the relative binding affinity of these steroids to cytoplasmic androgen receptor (AR) of hamster prostate was determined from, the corresponding IC50 values obtained from the competitive binding plots. The standards dihydrotestosterone (DHT) and cyproterone (CA) acetate used have displaced [3H]DHT from the AR with an IC50 value of 3.2 and 4.4 nM respectively. All steroidal compounds synthesized in this study showed a binding affinity for the androgen receptor, present in the cytosol from prostate hamster; compounds 10a-10c showed the highest affinities for this receptor. The in vivo experiments showed that all steroidal derivatives were subcutaneously active, since they decreased the weight of the prostate gland in gonadectomized hamsters treated with DHT, and are antagonists for the androgen receptor since they block the DHT-induced prostate weight gain. The derivatives having the more conjugated 4,16-pregnadiene-6, 20-dione system (10a-10c) exhibited a higher antiandrogenic activity than the corresponding steroids (17a-17d) based on the more saturated 4-pregnene-6,20-dione system.
Asunto(s)
Antagonistas de Andrógenos/metabolismo , Próstata/efectos de los fármacos , Unión Proteica/efectos de los fármacos , Receptores Androgénicos/metabolismo , Esteroides/metabolismo , Antagonistas de Andrógenos/síntesis química , Antagonistas de Andrógenos/farmacología , Antagonistas de Receptores Androgénicos , Animales , Cricetinae , Masculino , Mesocricetus , Próstata/metabolismo , Unión Proteica/fisiología , Esteroides/síntesis química , Esteroides/farmacologíaRESUMEN
The aim of this study is to determine the 5alpha-reductase inhibitory activity of several new steroidal compounds PR-01-PR-07 by measuring the conversion of [3H]T to[3H]DHT in Penicillium crustosum broths. These compounds were obtained from marine soft corals collected on the coasts of Andaman and Nicobar at Hori, Natkal and Kalipur (Diglipur) Islands and identified as Sinularia grandilobata Verseveldt, Sinularia crassa Tixier- Durivault, Sinularia gravis Tixier- Durivault, Sinularia sp., Lobophytum sp., Lobophytum crassum and Cladiella sp. PR-01-PR-04 significantly inhibited the conversion of [3H]T to [3H]DHT (P < 0.05) whereas PR-05 and PR-06 did not show an appreciable difference (P > 0.05) in this model. On the other hand PR-07 stimulated (P < 0.05) the enzymatic reaction.
Asunto(s)
Inhibidores de 5-alfa-Reductasa , Antozoos/química , Inhibidores Enzimáticos/farmacología , Esteroides/farmacología , 3-Oxo-5-alfa-Esteroide 4-Deshidrogenasa/metabolismo , Animales , Dihidrotestosterona/química , Dihidrotestosterona/metabolismo , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/aislamiento & purificación , Conformación Molecular , Monosacáridos/aislamiento & purificación , Monosacáridos/farmacología , Penicillium/efectos de los fármacos , Penicillium/enzimología , Penicillium/metabolismo , Esteroides/aislamiento & purificación , Testosterona/química , Testosterona/metabolismoAsunto(s)
Inhibidores de 5-alfa-Reductasa , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacología , Esteroides/síntesis química , Esteroides/farmacología , Animales , Cricetinae , Dihidrotestosterona/farmacología , Masculino , Orquiectomía , Tamaño de los Órganos/efectos de los fármacos , Vesículas Seminales/efectos de los fármacos , Relación Estructura-Actividad , Testosterona/farmacologíaAsunto(s)
Antagonistas de Andrógenos/química , Cristalografía por Rayos X , Pregnanodionas/química , Antagonistas de Andrógenos/síntesis química , Antagonistas de Andrógenos/farmacología , Humanos , Masculino , Modelos Químicos , Modelos Moleculares , Pregnanodionas/farmacología , Neoplasias de la Próstata/tratamiento farmacológico , Testosterona/químicaRESUMEN
The pharmacological activity of four new progesterone derivatives: 4-bromo-17alpha-(p-fluorobenzoyloxy)-4-pregnene-3,20-dione (7), 4-bromo-17alpha-(p-bromobenzoyloxy)-4-pregnene-3,20-dione (8), 4-bromo-17alpha-(p-chlorobenzoyloxy)-pregnene-3,20-dione (9) and 4-bromo-17alpha-(p-toluoyloxy)-4-pregnene-3,20-dione (10) was determined. These compounds were evaluated as 5alpha-reductase inhibitors on gonadectomized hamster seminal vesicles and flank organs. The pharmacological data of this study indicate that compounds 7 and 9 having at C-17 p-fluorobenzoyloxy and p-chlorobenzoyloxy ester functions respectively showed the highest antiandrogenic effect as measured by the reduction of the weight of the seminal vesicles. In the flank organ model, the same compounds 7 and 9 exhibited a smaller diameter, 1.8 and 1.0 mm, respectively, than the commercially available finasteride 3 (2.3 mm), thus indicating a higher inhibitory effect on 5alpha-reductase enzyme. Steroid 7 showed a higher inhibitory activity on the conversion of T to DHT (Fig. 3) than the presently used finasteride, thus indicating a higher antiandrogenic effect. The nonsubstituted benzoyloxy ester (compound 15) showed a lower antiandrogenic activity as measured in the seminal vesicles model than the p-substituted benzoyloxy compounds.
Asunto(s)
Inhibidores de 5-alfa-Reductasa , Inhibidores Enzimáticos/síntesis química , Progesterona/análogos & derivados , Progesterona/farmacología , Antagonistas de Andrógenos/síntesis química , Antagonistas de Andrógenos/farmacología , Animales , Cricetinae , Inhibidores Enzimáticos/farmacología , Ésteres/síntesis química , Ésteres/farmacología , Indicadores y Reactivos , Masculino , Mesocricetus , Orquiectomía , Tamaño de los Órganos/efectos de los fármacos , Pigmentación/efectos de los fármacos , Vesículas Seminales/efectos de los fármacos , Vesículas Seminales/metabolismoRESUMEN
The objective of this study was to synthesize several new pregnane derivatives and evaluate them as antiandrogens. From the commercially available 16-dehydropregnenolone acetate (7), two new steroidal compounds were synthesized: 17alpha-hydroxy-17beta-methyl-16beta-phenyl-D-homoandrosta-1,4,6-triene-3,20-dione (18) and 17alpha-acetoxy-17beta-methyl-16beta-phenyl-D-homoandrosta-1,4,6-triene-3,20-dione (19). The 5alpha-reductase inhibitory effect of the new compounds 18 and 19 together with the previously synthesized intermediates 7, 8, 13, 16, and 17 was determined in three different models: gonadectomized hamster flank organs diameter size, incorporation of [1,2-(14)C]sodium acetate into lipids in flank organs and conversion of [3H]testosterone (T) to [3H]dihydrotestosterone (DHT) by Penicillium crustosum. The evaluation of these steroids was carried out with three different controls: one group was treated with vehicle, the second with T and the third group with T plus finasteride. The pharmacological results from this work demonstrated that T significantly increases the diameter of the pigmented spot on the flank organs (p<0.05) as well as the incorporation of labeled sodium acetate into lipids in gonadectomized hamster flank organs (from 0.125 to 0.255 nmol per gland). In this study we also observed that broth of Penicillium crustosum converted [3H]T to [3H]DHT in a manner comparable to that of the flank organs. All experiments indicated that finasteride as well as steroids 7, 8, 13, 16-19 reduced significantly the conversion of T to DHT in P. crustosum. These compounds also decrease the size of the pigmented spot in the flank organs as well as reducing the incorporation of radiolabeled sodium acetate into lipids; T and the control sample (treated with vehicle only) were used for comparison. Apparently the presence of the 4,6-diene-3,20-dione moiety and also the C-17 ester group produce a higher inhibitory effect on the parameters used. PPThe data from this study indicated also that the three models used for the pharmacological evaluation exhibited comparable results.
Asunto(s)
Inhibidores de 5-alfa-Reductasa , Inhibidores Enzimáticos/farmacología , Pregnanos/farmacología , Animales , Cricetinae , Dihidrotestosterona/metabolismo , Lípidos/química , Masculino , Mesocricetus , Penicillium/efectos de los fármacos , Penicillium/enzimología , Relación Estructura-Actividad , Testosterona/metabolismoAsunto(s)
Metabolismo de los Lípidos , Piel/metabolismo , Acetato de Sodio/metabolismo , Esteroides/farmacología , Inhibidores de 5-alfa-Reductasa , Animales , Cricetinae , Inhibidores Enzimáticos/administración & dosificación , Inhibidores Enzimáticos/farmacología , Finasterida/farmacología , Inyecciones Subcutáneas , Masculino , Orquiectomía , Pigmentación/efectos de los fármacos , Piel/efectos de los fármacos , Esteroides/administración & dosificaciónRESUMEN
Antiandrogens have high impact in medicine as they are compounds capable of decreasing the effect of benign prostatic hyperplasia, cancer, and other androgen-dependent diseases that affect a large percentage of the male population in the world. [figure: see text] Dihydrotestosterone, a 5 alpha-reductase metabolite of testosterone, has been implicated as the responsible factor of these androgen abnormalities. This fact indicates that the logical step in the treatment of these diseases is the inhibition of this enzyme activity using molecules that compete selectively with its natural substrates. The study of the pharmacological effect of antiandrogens requires specific animal models using a large number of laboratory animals. On basis of this concept, presently there is a tendency to eliminate studies with animals. In this paper we report a new method for antiandrogenic evaluation using microbial transformations.
Asunto(s)
Antagonistas de Andrógenos/farmacología , Penicillium/efectos de los fármacos , Animales , Cricetinae , Dihidrotestosterona/metabolismo , Electroforesis en Gel de Poliacrilamida , Inhibidores Enzimáticos/farmacología , Finasterida/farmacología , Masculino , Modelos Biológicos , Peso Molecular , Penicillium/metabolismo , Testosterona/metabolismoRESUMEN
These results indicate that castration decreased the flank organ diameter and the weight of the seminal vesicles, whereas daily injection of testosterone restores them. However injections of finasteride together with testosterone inhibited the diameter of the flank organs, the weight of the seminal vesicles, and the conversion of testosterone to dihydrotestosterone. The four compounds tested inhibited flank organ diameter size and the weight of the seminal vesicles as compared to the testosterone-treated animals. On the other hand, none of these compounds suppressed the conversion of testosterone to dihydrotestosterone. These results suggest that the synthesized steroids compete with androgen receptors.
Asunto(s)
Antagonistas de Andrógenos/farmacología , Esteroides/farmacología , Animales , Cricetinae , Dihidrotestosterona/metabolismo , Finasterida/farmacología , Técnicas In Vitro , Masculino , Orquiectomía , Vesículas Seminales/efectos de los fármacos , Vesículas Seminales/metabolismo , Testosterona/antagonistas & inhibidores , Testosterona/metabolismo , Testosterona/farmacologíaRESUMEN
The pharmacological activities of 12 pregnane derivatives (4-15) were determined on gonadectomized male hamster flank organs and seminal vesicles as antiandrogens and as 5alpha-reductase inhibitors. The results from this study indicate that subcutaneous injection of testosterone for 3 d increased the diameter of the pigmented spot in the flank organs, whereas finasteride when injected with testosterone decreased the size of the spot significantly when steroids 4-15 were injected together with testosterone, the diameter of the flank organs of gonadectomized male hamsters, decreased significantly (p<0.005) compared to testosterone. Compound 11 was the most active steroid and reduced the diameter of the pigmented spot more than the other synthesized steroids or finasteride. Subcutaneous injections of testosterone to gonadectomized animals restore the seminal vesicle size lost upon castration. Injection of testosterone plus finasteride decreased significantly the weight of these glands (p<0.005). Steroids 5-15 when injected with testosterone decreased the weight of the seminal vesicles compared to testosterone. Finasteride is a good inhibitor of the conversion of testosterone to dihydrotestosterone (DHT) (low formation of DHT) measured as pmole of DHT/g of protein/h. Steroids 6-15 inhibited the conversion of testosterone to DHT as compared to testosterone however finasteride and 10 appeared to be the most effective compounds. Castration increases the protein content of the seminal vesicles (control) expressed as microg/mg of tissues. Testosterone tends to decrease it significantly, as did compounds 4, 5, 7, 9, and 15. We demonstrated that DHT as well as cyproterone acetate and steroids 5, 6, 8, 9, 11, and 14 at increasing non radioactive steroid concentration, inhibited the binding of [3H]DHT to cytosolic androgen receptor (AR), as indicated by its Ki values. However, 4, 7, 10, 12, and 13 did not have any inhibitory effect.
Asunto(s)
Antagonistas de Andrógenos/síntesis química , Pregnanos/síntesis química , Antagonistas de Andrógenos/farmacología , Animales , Unión Competitiva/efectos de los fármacos , Cricetinae , Citosol/efectos de los fármacos , Citosol/metabolismo , Dihidrotestosterona/metabolismo , Genitales Masculinos/efectos de los fármacos , Técnicas In Vitro , Masculino , Mesocricetus , Orquiectomía , Tamaño de los Órganos , Pregnanos/farmacología , Proteínas/metabolismo , Vesículas Seminales/efectos de los fármacos , Testosterona/metabolismoRESUMEN
The purpose of this work is to synthesize a pregnane derivative with a high antiandrogenic effect or a high inhibitory activity for the enzyme 5 alpha-reductase type 2. Benign prostatic hyperplasia and prostate cancer are androgen dependent diseases which afflict a large percentage of the male population. Dihydrotestosterone 3, a 5 alpha-reductase metabolite of testosterone 2 has been implicated as a causative factor in the progression of these diseases, largely through the clinical evaluation of males who are genetically deficient of steroid 5 alpha-reductase enzyme. As a result of this study, the inhibition of this enzyme has become a pharmacological strategy for the design and synthesis of new drugs. The advent of finasteride 22 "figure 5" a 5 alpha-reductase inhibitor, has greatly alleviated the symptoms associated with benign prostatic hyperplasia. On the other hand, the discovery of cyproterone acetate 4 "figure 2" alone or in combination with the antiandrogens flutamide 14 "figure 3" or bicalutamide 21 has greatly reduced the misery of prostate cancer. Prostate cancer kills about 40,000 men in the USA and approximately 400,000 prostatectomies are performed each year. In our laboratory we have recently synthesized ten new progesterone derivatives 17 alpha-acyloyloxy-6-halo (chloro, bromo) 16 beta-methyl-4, 6-pregnadiene-3, 20-diones (54a-54e and 55a-55e), "figure 10". These steroids were evaluated as antiandrogens and exhibited a much higher activity than the commercially available cyproterone acetate 4. The same compounds were also evaluated as 5 alpha-reductase inhibitors and showed a slightly higher inhibitory activity than that of finasteride 22, the drug of choice today for the treatment of benign prostatic hyperplasia In another study we synthesized several new 4-halo (bromo and chloro) 17 alpha-benzoyloxy and also 4-halo-17 alpha-acetoxy progesterone derivatives (58-63) "figure 13". These compounds were prepared from the commercially available 17 alpha-acetoxy progesterone 56. The pharmacological evaluation of these steroids "figure 14" indicated that the 17 alpha-benzoyloxy derivatives (4-chloro and bromo) 62 and 63 were very potent antiandrogens. On the other hand, the 4-halo (bromo and chloro) 17 alpha-acetoxy (58, 59) and the 17 alpha-benzoyloxy-4-chloro analog 63 showed a very high inhibitory activity for the enzyme 5 alpha-reductase type 2 "figure 15".
Asunto(s)
Antagonistas de Andrógenos/síntesis química , Oxidorreductasas/antagonistas & inhibidores , Antagonistas Adrenérgicos/farmacología , Antagonistas de Andrógenos/farmacología , Antagonistas de Andrógenos/uso terapéutico , Andrógenos/fisiología , Colestenona 5 alfa-Reductasa , Hormona Liberadora de Gonadotropina/agonistas , Humanos , Masculino , Oxidorreductasas/metabolismo , Progesterona/análogos & derivados , Progesterona/síntesis química , Progesterona/farmacología , Neoplasias de la Próstata/tratamiento farmacológicoRESUMEN
The pharmacological activity of eight pregnane derivatives 17-alpha acetoxyprogesterone 9, 17-alpha acetoxy-4, 5-epoxypregnan-3, 20-dione 10, 17-alpha acetoxy-4-chloro-4-pregnene-3, 20-dione 11, 17-alpha acetoxy-4-bromo-4-pregnene-3, 20-dione 12, 17-alpha hydroxy-4-bromo-4-pregnene-3, 20-dione 13, 4-chloro-17-alpha hydroxy-4-pregnene-3, 20-dione 14, 17-alpha benzoyloxy-4-bromo-4-pregnene-3, 20-dione 15 and 17-alpha benzoyloxy-4-chloro-4-pregnene-3, 20-dione 16 was determined. These compounds were evaluated as antiandrogens on gonadectomized hamster seminal vesicles. The pharmacological data in this study indicate that compounds 15 and 16 having a C-17 benzoyloxy moiety showed the highest antiandrogenic activity as measured by the reduction of the weight of the seminal vesicles, followed by the steroids 11 and 12 (17-alpha acetoxy group). The free alcohols 13 and 14 exhibited a lower antiandrogenic activity. Apparently, the ester moiety at C-17 is a necessary requirement for the presence of high antiandrogenic activity. Shows the inhibitory effect on the conversion of testosterone (T) to DHT, of the above described steroids as measured by the amount of produced DHT 2 expressed as pmoles of DHT/g of protein/h. Steroids 11, 12 and 16 showed a much higher inhibitory activity on the conversion of testosterone (T) to dihydrotestosterone (DHT) than presently used finasteride 3.
Asunto(s)
Antagonistas de Andrógenos/síntesis química , Pregnanos/síntesis química , 3-Oxo-5-alfa-Esteroide 4-Deshidrogenasa/metabolismo , Antagonistas de Andrógenos/farmacología , Animales , Cromatografía en Capa Delgada , Cricetinae , Dihidrotestosterona/farmacología , Técnicas In Vitro , Masculino , Mesocricetus , Orquiectomía , Tamaño de los Órganos/efectos de los fármacos , Pregnanos/farmacología , Biosíntesis de Proteínas , Ratas , Vesículas Seminales/efectos de los fármacos , Vesículas Seminales/enzimología , Vesículas Seminales/crecimiento & desarrollo , Testosterona/metabolismoRESUMEN
The pharmacological activities of four pregnane derivatives: 17alpha-hydroxy-16beta-methylpregna-4,6-diene-3,20-dio ne (7), 17alpha-acetoxy-16beta-methylpregna-4,6-diene-3,20-dio ne (8), 17alpha-acetoxy-6-bromo-16beta-methylpregna-4,6-diene- 3,20-dione (10), and 17alpha-acetoxy-6-chloro-16beta-methylpregna-4,6-diene -3,20-dione (11), were determined. The derivatives were evaluated on gonadectomized male hamster flank organs and seminal vesicles. The results indicate that topical applications of testosterone (T) on the flank organs increased the diameter of the pigmented spot. Similarly, the same phenomenon occurred on the glands treated with compound 11, whereas compound 10 decreased the size of the spot significantly. In this study, we determined the effects of several new steroids on the conversion of T to DHT in flank organs and seminal vesicles. The results show that compound 10 inhibited T conversion to DHT, but compound 11, at a dose of 200 microg, stimulated T conversion in both flank organs and seminal vesicles. However, when 2 mg of compound 11 was applied, it inhibited the conversion of T to DHT, suggesting that this compound also represses gonadotropin release. The difference between compounds 10 and 11 involves the electronegativity of the halogen at the C-6 position of the progesterone skeleton. These data clearly indicate that by decreasing the electronegativity of the halogen at C-6 (compound 10), 5alpha-reductase is inhibited in both tissues and at different pHs. On the other hand, when the electronegativity of the halogen atom was increased (11), there was a much lower inhibitory effect on the conversion of T to DHT.